12. tbl. 97. árg. 2011
Medication use among community-dwelling older Icelanders. Population-based study in urban and rural areas
Lyfjanotkun eldri Íslendinga sem búa heima. Lýðgrunduð rannsókn í dreifbýli og þéttbýli
Objective: To describe medication use among older community-dwelling Icelanders by collecting information on number of medicine, polypharmacy (>5 medications), and medications by ATC categories. Moreover, to explore the relationship between medication use and various influential factors emphasizing residency in urban and rural areas.
Material and methods: Population-based, cross-sectional study. Participants were randomly selected from the National registry in one urban (n=118) and two rural (n=68) areas. Inclusion criteria: 1) ≥65 years old, 2) community-dwelling, 3) able to communicate verbally. Information on medication use was obtained from each person's medication list and interviews. A questionnaire and five standardized instruments were used to assess the potential influencing factors.
Results: On average, participants used 3.9 medications and prevalence of polypharmacy was 41%. Men used 3.5 medications on average and women 4.4 (p=0.018). Compared to rural residents, urban residents had fewer medical diagnoses, better mobility, less pain, and fewer depressive symptoms. By controlling for the effects of these variables, more medications were associated with urban living (p<0.001) and more medical diagnoses (p<0.001). Likewise, adjusted odds for polypharmacy increased with urban residency (p=0.023) and more medical diagnoses (p=0.005). Urban residency, more medical diagnoses, higher age, and male gender were related to use of drugs for blood and blood forming organs.
Conclusion: The results reveal an unexplained regional difference in medications use by older Icelanders. Further studies are required on why urban residents use at least equal amount of medications as rural residents despite better scores on health assessments.
Table I. Description of participants, contextual factors and medication use.
|
||||
|
Mean (standard deviation) [range] or number (%*) | p‡ | ||
Total † N = 186 |
Urban n = 118 |
Rural n = 68 |
||
Age, years | 74 (6,3)[65-88] | 74 (6,3) [65-88] | 74 (6,2) [65-86] | 0,658 |
Age group: | ||||
65-74 years | 114 (61%) | 73 (62%) | 41 (60%) | |
75-88 years | 72 (39%) | 45 (38%) | 27 (40%) | 0,832 |
Gender: | ||||
Woman | 89 (48%) | 62 (52%) | 27 (40%) | |
Man | 97 (52%) | 56 (48%) | 41 (60%) | 0,091 |
Education, years | 7,5 (3,3) [0-20] | 8,2 (3,6) [0-20] | 6,3 (2,2) [3-13] | <0,001 |
Adequate income | 123 (66%) | 88 (75%) | 35 (52%) | <0,001 |
Living alone | 45 (24%) | 35 (30%) | 10 (15%) | 0,022 |
Home nursing service | 16 (9%) | 10 (9%) | 6 (9%) | 0,949 |
Social domestic service | 63 (34%) | 39 (33%) | 24 (35%) | 0,787 |
Number of diagnosed diseases | 3,2 (1,8) [0-9] | 2,7 (1,6 [0-7] | 4,1 (1,8) [0-9] | <0,001 |
Body mass index (BMI), kg/m2 | 27 (3,8) [17-39] | 27(3,8) [17-39] | 27(3,6) [19-36] | 0,872 |
Physical activity (PASE), 0-400+ | 127 (92) [0-513] | 126(87) [0-425] | 130(101) [0-513] | 0,782 |
Physical function (TUG), sek | 11 (3,6) [5-24] | 10 (3,4) [5-24] | 12 (3,4) [7-23] | <0,001 |
Pain (SF-36), 0-100 | 65 (41) [0-100] | 73 (40) [0-100] | 50 (37) [0-100] | <0,001 |
Depressive symptoms (GDS), 0-30 | 6,5 (4,3) [1-20] | 5,6 (3,8) [1-20] | 8,1 (4,6) [1-20] | <0,001 |
Cognitive function (MMSE), 0-30 | 27 (2,5) [16-30] | 27 (2,5) [16-30] | 27 (2,7) [21-30] | 0,793 |
Number of medicine | 3,9 (2,7) [0-12] | 4,0 (2,8) [0-12] | 3,8 (2,6) [0-11] | 0,622 |
Polypharmacy (≥ 5 drugs) | 76 (41%) | 47 (40%) | 29 (43%) | 0,707 |
* Proportions (%) are based on valid data for each variable; †based on nonweighted data; ‡ p values indicate the significance of differences between rural and urban participants; PASE = Physical Activity Scale for the Elderly; TUG = Timed Up and Go; SF-36 = Short Form 36-item health survey; GDS = Geriatric Depression Scale; MMSE = Mini-Mental State Examination. |
Table II. Comparison of ATC medication use, in 13 ATC categories, by urban and rural residency.
|
||||
ATC-group
|
Total* n =186 |
Urban n=118 |
Rural n=68 |
p† |
A – Alimentary tract and metabolism | 65 (34,9%) | 40 (33,9%) | 25 (36,8%) | 0,693 |
B – Blood and blood forming organs | 67 (36%) | 46 (39%) | 21 (30,9%) | 0,268 |
C – Cardiovascular system | 123 (66,1%) | 78 (66,1%) | 45 (66,2%) | 0,902 |
D - Dermatologicals | 1 (0,5%) | 0 (0%) | 1 (1,5%) | 0,187 |
G – Genito-urinary system and sex hormones | 15 (8,1%) | 9 (7,6%) | 6 (8,8%) | 0,773 |
H – Systemic hormonal preparations, excluding sex hormones and insulins | 23 (12,4%) | 15 (12,7%) | 8 (11,8%) | 0,850 |
J – Antiinfectives for systemic use | 5 (2,7%) | 2 (1,7%) | 3 (4,4%) | 0,270 |
L – Antineoplastic and immunomodulating agents | 4 (2,2%) | 1 (0,8%) | 3 (4,4%) | 0,107 |
M – Musculo-skeletal system | 42 (22,6%) | 25 (21,2%) | 17 (25%) | 0,549 |
N – Nervous system | 69 (37,1%) | 43 (36,4%) | 26 (38,2%) | 0,807 |
P – Antiparasitic products, insecticides and repellents | 1 (0,5%) | 0 (0%) | 1 (1,5%) | 0,187 |
R – Respiratory system | 22 (11,8%) | 16 (13,6%) | 6 (8,8%) | 0,335 |
S – Sensory organs | 6 (3,2%) | 1 (0,8%) | 5 (7,4%) | 0,016 |
*Based on nonweighted data; † p values indicate the significance of differences between medication use in urban and rural areas. |
Table III. Independent association between nine explanatory factors and the four most prevalent ATC classifications. The four multivariate models are based on logistic regression analysis on weighted data.
|
||||||||
Alimentary tract and metabolism | Blood and blood forming organs | Cardiovascular system | Nervous system | |||||
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
Gender (0 = woman, 1 = man) | 0,72 | 0,33 – 1,6 | 3,65** | 1,53 – 8,71 | 1,11 | 0,47 – 2,63 | 0,91 | 0,37 – 2,22 |
Recidency (0 = rural, 1 = urban) | 1,31 | 0,58 – 2,99 | 2,99* | 1,16 – 7,71 | 2,18 | 0,85 – 5,58 | 2,12 | 0,83 – 5,42 |
Age | 1,04 | 0,97 – 1,12 | 1,15** | 1,06 – 1,25 | 1,06 | 0,97 – 1,16 | 1 | 0,92 – 1,08 |
Cognitive function (MMSE) | 0,98 | 0,81 – 1,19 | 0,91 | 0,77 – 1,08 | 0,88 | 0,72 – 1,09 | 0,88 | 0,75 – 1,03 |
Depressive symptoms (GDS) | 1,02 | 0,91 – 1,4 | 1 | 0,87 – 1,13 | 0,91 | 0,75 – 1,11 | 1,26** | 1,09 – 1,45 |
Physical function (TUG) | 0,92 | 0,81 – 1,06 | 1,01 | 0,89 – 1,15 | 1,01 | 0,85 – 1,17 | 1,02 | 0,87 – 1,21 |
Physical activity (PASE) | 1 | 0,99 – 1,01 | 1 | 0,99 – 1,01 | 1 | 0,99 – 1,01 | 0,99* | 0,98 – 0,99 |
Pain (SF-36) | 1 | 0,99 – 1,01 | 1 | 0,99 – 1,01 | 1 | 0,99 – 1,01 | 0,99 | 0,98 – 1 |
Number of diagnosed diseases | 1,31 | 1– 1,72 | 2,42* | 1,06 – 1,81 | 1,97** | 1,3 – 2,92 | 0,96 | 0,7 – 1,33 |
OR = Odds Ratio; CI = Confidence Interval; MMSE = Mini-Mental State Examination; GDS = Geriatric Depression Scale; TUG = Timed Up and Go; PASE = Physical Activity Scale for the Elderly; SF-36 = Short-Form Health Survey; * p < 0,05; ** p < 0,01. |